ロード中...
6ER-002 Assessement of efficacy of proprotein convertase subtilisin/kexin type 9 inhibitors (i-pcsk9) for hypercholesterolaemia with or without statins
BACKGROUND: Proprotein inhibitors convertase subtilisin/kexin9 (i-PCSK9) are new drugs for hypercholesterolaemia used in monotherapy or in combination with statins, which have numerous interactions. It may be useful to study the efficacy of I-PCSK9 as a single therapy. PURPOSE: To compare the effica...
保存先:
| 出版年: | Eur J Hosp Pharm |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Group
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7535384/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.495 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|